ArticleFuture oncology (London, England)2025
Real-world survival outcomes and MDM2 prevalence in US patients with metastatic dedifferentiated liposarcoma.
Steven Robinson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it